Anxiety and Depression in Children with Irritable Bowel Syndrome-A Narrative Review

Daniela Pop1,2, Sorin Claudiu Man1,2, Dorin Farcău2,3

  • 1Third Pediatric Discipline, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400217 Cluj-Napoca, Romania 2 Third Pediatric Department, Emergency Hospital for Children, 400217 Cluj-Napoca, Romania 3 Nursing Discipline, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400217 Cluj-Napoca, Romania.

PubMed

Insights

Pediatric Irritable Bowel Syndrome (IBS) is linked to psychological factors like anxiety and depression, impacting gut-brain communication. Therapies targeting these psychological issues show promise for managing childhood IBS symptoms.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology
  • Neurogastroenterology

Background:

  • Irritable Bowel Syndrome (IBS) is a prevalent functional gastrointestinal disorder in children.
  • Psychological conditions, including anxiety and depression, are recognized as potential risk factors for pediatric IBS.
  • The gut-brain axis and serotonin signaling play crucial roles in the pathophysiology of both gastrointestinal and psychological disorders.

Purpose of the Study:

  • To investigate the genetic, pathophysiological, and clinical connections between psychological factors (anxiety, depression) and IBS in children.
  • To evaluate the efficacy of psychological therapies for treating IBS in pediatric populations.
  • To highlight the long-term impact of childhood psychological events on gastrointestinal health.

Main Methods:

  • Literature review examining studies on the links between psychological factors and pediatric IBS.
  • Analysis of the role of gut-brain axis dysfunction and serotonin signaling.
  • Evaluation of evidence for therapies such as antidepressants, hypnotherapy, and cognitive behavioral therapy (CBT).

Main Results:

  • Impaired gut-brain communication and altered serotonin signaling are implicated in both IBS and psychological disorders in children.
  • Childhood psychological experiences may contribute to gastrointestinal symptoms persisting into adulthood.
  • Therapies targeting psychological distress, including CBT and hypnotherapy, demonstrate potential benefits for children with IBS.

Conclusions:

  • A significant link exists between psychological factors like anxiety and depression and the development of IBS in children.
  • Further research with standardized criteria and outcome measures is necessary to solidify understanding and treatment strategies.
  • Addressing psychological comorbidities is essential for comprehensive management of pediatric IBS.

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
218
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
108
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
137
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
140
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
294